4.7 Article

CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia

Journal

JOURNAL OF HEMATOLOGY & ONCOLOGY
Volume 7, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s13045-014-0069-1

Keywords

lncRNAs; CEBPA; AML

Funding

  1. Research Projects of National Interest (PRIN)
  2. FP7-PEOPLE-ITN Project [289611]
  3. Italian Epigenomics Flagship Project (EPIGEN)

Ask authors/readers for more resources

CCAAT/enhancer-binding protein-alpha (CEBPA) is a critical regulator of myeloid differentiation. Disruption of CEBPA function contributes to the development of acute myeloid leukemia (AML). CEBPA regulates a large number of protein coding genes of which several were shown to contribute to CEBPA function. In this study, we expand the analysis of CEBPA transcriptional targets to the newly identified class of long non-coding RNAs. We show that lncRNAs are a main component of the transcriptional program driven by C/EBP alpha and that many of these are also induced during granulocytic differentiation of AML cell lines supporting their relevance in proliferation arrest and differentiation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available